Saturday, 22 June 2024 01:02 AM
Class Action
NEW YORK, NY / ACCESSWIRE / June 22, 2024 / GoodRx Holdings, Inc. (NASDAQ:GDRX)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information about the Company's business and operations. GoodRx generates a portion of its revenue from subscription plans like the "Kroger Rx Savings Club," which provides "access [to] lower prescription prices at" pharmacies operated by The Kroger Co. Throughout the Relevant Period, the Company made materially false and/or misleading statements and/or failed to disclose that: (i) while Kroger accounted for less than 5% of the pharmacies accepting GoodRx discounts, Kroger was responsible for nearly 25% of GoodRx's total prescription transactions revenue (the Company's primary revenue stream); (ii) Kroger could unilaterally cease accepting GoodRx discounts, cutting off some or all of GoodRx's revenues for purchases at Kroger's pharmacies; and (iii) as a result, the Company's representations about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.
If you are a GDRX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Doximity, Inc. (NYSE:DOCS)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information about the Company's business and operations. Specifically, the Company repeatedly touted its business prospects and the sustainability of the Company's revenue growth and profitability, while downplaying the impact of competition and tightening macroeconomic conditions on the Company and Doximity's reliance on "upselling" products and services (such as additional advertising) to existing customers to sustain the Company's performance and future growth.
If you are a DOCS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
agilon health, inc. (NYSE:AGL)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company misled investors about the Company's medical costs by: (i) touting the Company's purported visibility into utilization trends and medical costs; (ii) failing to disclose increased medical costs that the Company had incurred due to higher utilization of healthcare by Medicare Advantage patients; (iii) falsely stating that its IBNR Reserve was adequate; (iv) making false and misleading statements about the effectiveness of its business model; (v) issuing overly optimistic financial guidance; and (vi) issuing risk disclosures that were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities.
If you are an AGL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Sharecare, Inc. (NASDAQ:SHCR)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information that: (i) Sharecare lacked adequate internal controls; and (ii) as a result, the Company's statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.
If you are a SHCR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
ATTORNEY ADVERTISING.© 2024 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]
SOURCE: Lifshitz Law Firm, P.C.